Opioid Policies

collage

Much like the rest of the United States, residents of the District of Columbia are struggling with substance use disorder (SUD) rate increases and high rates of opioid-related deaths. Unfortunately, these are multi-faceted issues that require year-long initiatives and systematic programs to address the myriad causes of addiction.

MSDC stands as a partner to the District government and private entities to help arrest the rates of opioid and substance abuse in the District. Through our advocacy for better prescribing practices, education on addiction, and even helping our own community through our Physician Health Program, MSDC is working to make DC a leader in reducing SUD, OUD, and addiction.

On a related note, MSDC is passionate about helping patients make prescriptions and medication more affordable. Whether expanding access to biosimilars or advocating for more affordable co-pays, MSDC wants to help our patients afford the medications they need.

MSDC Statement and Testimony on Opioid and Prescription Issues

25th Council information coming soon

 

We want your prior auth stories

Jun 30, 2022, 10:39 AM by MSDC staff
Send MSDC your prior auth stories to help us pass the prior authorization reform bill.

The #FixDCPriorAuth campaign continues.

As the summer heat sets into DC, it is more critical than ever to remind the Council, Bowser administration, and public that prior authorizations harm care and real reform can be passed this year. One of the most effective ways to do this is to make it clear that prior authorizations harm all kinds of patient care. Often people have one or two personal experiences with a prior auth, but they may not realize that it touches every part of medicine.

To help make clear how widespread prior auths are, send us your stories about how a prior authorization impacted you, your patient, or your practice.

We will keep you anonymous (or share your name if you want) but we will use these stories to show policymakers, the media, and the public how important of an issue this is. We will also include them on our Prior Auth Reform page.

Below are some examples we have already collected. Send your examples to hay@msdc.org:

My patient was denied access to a particular birth control pill she had been on successfully before, and my office was told she needed to try and fail on 5 different generic pills before she could be approved. - OB/GYN

I spent 90 minutes of time with the prior authorization department and an additional 30 minutes with the pharmacy and the patient all because they changed their formulary and would not "grandfather him in". - Psychiatrist

Load more comments
avatar
New code

Sample of Legislation MSDC Tracked on Opioid and Prescription Policy

 

Access to Biosimilars Amendment Act (B23-430)

What does it do? The bill authorizes licensed pahrmacists to dispense interchangeable biological products and requires notifications to physicians when such interchangeables are dispensed.

MSDC position: MSDC has a position of priority support on this legislation, identifying its passage as one of its highest legislative priorities.

Current status: SUCCESS. The bill was passed by the Council and signed by the Mayor.

Opioid Labeling Amendment Act (B23-535)

What does it do? The bill requires prescription opioid medications to include a statement that the drug is an opioid and opioids may cause dependence, addiction, or overdoes.

MSDC position: MSDC supports the legislation.

Current status: The bill had a hearing before the Committee on Health on July 29, 2020. MSDC leader Dr. Sam Kareff testified for the Medical Society. It passed the Council on November 10 and was signed by the Mayor December 7.

Pre-exposure Prophylaxis Insurance Discrimination Amendment Act (B23-36)

What does it do? The bill prohibits insurance companies from factoring the use of PreP in decisions related to disability, life, or long-term care policies.

MSDC position: MSDC supports this legislation

Current status: The bill was introduced on January 8, 2019 and assigned to the Committee on Business and Economic Development.